Orbimed Advisors LLC

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-15
Total Holdings: 107
Total Value: 4035711615
Accession Number: 0001172661-25-002355
Form Type: 13F-HR
CIK: 0001055951
Manager Name: Orbimed Advisors LLC

Data Enrichment

92% identified

98 identified9 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

107 positions • $4,035,711.615K total value

107 positions

Manager:

SEC FilingSEC DataHachi Filing

Search and click to pin securities to the top

Page 4 of 6

Sort by:

Adicet Bio, Inc.

ACET|007002108

11447140(+0.0%)

Value:

$8.6B(-21.5%)

ADC Therapeutics SA

ADCT|H0036K147

5968451(+0.0%)

Value:

$8.4B(-29.1%)

Prelude Therapeutics Inc

PRLD|74065P101

10909256(+0.0%)

Value:

$8.4B(-39.8%)

78464A870

100000(-73.1%)

Value:

$8.1B(-75.8%)

Avalo Therapeutics, Inc.

AVTX|05338F306

967000(+0.0%)

Value:

$7.7B(+7.8%)

SpringWorks Therapeutics, Inc.

SWTX|85205L107

172600(-86.2%)

Value:

$7.6B(-83.2%)

Whitehawk Therapeutics, Inc.

WHWK|00032Q104

4166000

Value:

$7.4B

Akero Therapeutics, Inc.

AKRO|00973Y108

179900(+172.6%)

Value:

$7.3B(+296.6%)

PMV Pharmaceuticals, Inc.

PMVP|69353Y103

6475291(+0.0%)

Value:

$7.1B(-27.8%)

Trevi Therapeutics, Inc.

TRVI|89532M101

1120000

Value:

$7.0B

G52441105

250000

Value:

$6.2B

Corbus Pharmaceuticals Holdings, Inc.

CRBP|21833P301

1172287(+0.0%)

Value:

$6.2B(-55.0%)

45779A846

2133405(+0.0%)

Value:

$5.7B(+2.3%)

Scholar Rock Holding Corp

SRRK|80706P103

151800(+0.0%)

Value:

$4.9B(-25.6%)

Forte Biosciences, Inc.

FBRX|34962G208

593088(-1.1%)

Value:

$4.6B(-66.2%)

Ikena Oncology, Inc.

IKNA|45175G108

3539358(+0.0%)

Value:

$4.5B(-21.9%)

000000000

5680186(+0.0%)

Value:

$4.4B(-39.8%)

Krystal Biotech, Inc.

KRYS|501147102

23500(+0.0%)

Value:

$4.2B(+15.1%)

29286M105

891616(-3.1%)

Value:

$4.0B(-34.7%)

Oric Pharmaceuticals, Inc.

ORIC|68622P109

700000

Value:

$3.9B

Instrument	Shares		Other Manager	Value
Adicet Bio, Inc.(ACETcusip007002108)	11.4M	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$8.6M	QoQ -21.51% (-$2.4M) YoY -67.87% (-$18.3M)
Adc Therapeutics Sa(ADCTcusipH0036K147)	6.0M	QoQ 0.00% (-0) YoY NEW(+6.0M)	All Managers (Combined)	$8.4M	QoQ -29.14% (-$3.5M) YoY NEW(+$8.4M)
Prelude Therapeutics Inc(PRLDcusip74065P101)	10.9M	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$8.4M	QoQ -39.76% (-$5.5M) YoY -83.79% (-$43.3M)
(cusip78464A870)✕	100.0K	QoQ -73.11% (-272.0K) YoY NEW(+100.0K)	All Managers (Combined)	$8.1M	QoQ -75.79% (-$25.4M) YoY NEW(+$8.1M)
Avalo Therapeutics, Inc.(AVTXcusip05338F306)	967.0K	QoQ 0.00% (+0) YoY NEW(+967.0K)	All Managers (Combined)	$7.7M	QoQ +7.80% (+$560.9K) YoY NEW(+$7.7M)
Springworks Therapeutics, Inc.(SWTXcusip85205L107)	172.6K	QoQ -86.24% (-1.1M) YoY -89.89% (-1.5M)	All Managers (Combined)	$7.6M	QoQ -83.20% (-$37.7M) YoY -90.93% (-$76.4M)
Whitehawk Therapeutics, Inc.(WHWKcusip00032Q104)	4.2M	QoQ NEW(+4.2M) YoY NEW(+4.2M)	All Managers (Combined)	$7.4M	QoQ NEW(+$7.4M) YoY NEW(+$7.4M)
Akero Therapeutics, Inc.(AKROcusip00973Y108)	179.9K	QoQ +172.57% (+113.9K) YoY NEW(+179.9K)	All Managers (Combined)	$7.3M	QoQ +296.61% (+$5.4M) YoY NEW(+$7.3M)
Pmv Pharmaceuticals, Inc.(PMVPcusip69353Y103)	6.5M	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$7.1M	QoQ -27.81% (-$2.7M) YoY -35.88% (-$3.9M)
Trevi Therapeutics, Inc.(TRVIcusip89532M101)	1.1M	QoQ NEW(+1.1M) YoY NEW(+1.1M)	All Managers (Combined)	$7.0M	QoQ NEW(+$7.0M) YoY NEW(+$7.0M)
(cusipG52441105)✕	250.0K	QoQ NEW(+250.0K) YoY NEW(+250.0K)	All Managers (Combined)	$6.2M	QoQ NEW(+$6.2M) YoY NEW(+$6.2M)
Corbus Pharmaceuticals Holdings, Inc.(CRBPcusip21833P301)	1.2M	QoQ 0.00% (-0) YoY NEW(+1.2M)	All Managers (Combined)	$6.2M	QoQ -55.00% (-$7.6M) YoY NEW(+$6.2M)
(cusip45779A846)✕	2.1M	QoQ 0.00% (+0) YoY 0.00% (+0)	All Managers (Combined)	$5.7M	QoQ +2.28% (+$128.0K) YoY +13.49% (+$682.5K)
Scholar Rock Holding Corp(SRRKcusip80706P103)	151.8K	QoQ 0.00% (-0) YoY -95.75% (-3.4M)	All Managers (Combined)	$4.9M	QoQ -25.61% (-$1.7M) YoY -92.31% (-$58.6M)
Forte Biosciences, Inc.(FBRXcusip34962G208)	593.1K	QoQ -1.15% (-6.9K) YoY NEW(+593.1K)	All Managers (Combined)	$4.6M	QoQ -66.22% (-$9.0M) YoY NEW(+$4.6M)
Ikena Oncology, Inc.(IKNAcusip45175G108)	3.5M	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$4.5M	QoQ -21.95% (-$1.3M) YoY -9.85% (-$495.5K)
(cusip000000000)✕	5.7M	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$4.4M	QoQ -39.76% (-$2.9M) YoY -83.79% (-$22.6M)
Krystal Biotech, Inc.(KRYScusip501147102)	23.5K	QoQ 0.00% (+0) YoY -36.77% (-13.7K)	All Managers (Combined)	$4.2M	QoQ +15.09% (+$555.5K) YoY -35.92% (-$2.4M)
(cusip29286M105)✕	891.6K	QoQ -3.12% (-28.7K) YoY NEW(+891.6K)	All Managers (Combined)	$4.0M	QoQ -34.73% (-$2.1M) YoY NEW(+$4.0M)
Oric Pharmaceuticals, Inc.(ORICcusip68622P109)	700.0K	QoQ NEW(+700.0K) YoY +143.81% (-412.9K)	All Managers (Combined)	$3.9M	QoQ NEW(+$3.9M) YoY -1.05% (-$41.6K)